Aurobindo Pharma
AUROPHARMA
Quick Bite
Price To Earnings Ratio 22.21 | Sector PE 64.19 |
PB Ratio 2.36 | Sector PB 8.77 |
EPS 54.16 | Dividend Yield 0.41 |
Today's Volume 425.364 K | 5 Day Avg. Volume 865.598 K |
PEG Ratio 0.34 | Market Cap. ₹ 72,540.00 Cr. |
Returns Comparison
| Time | AUROPHARMA | VS | Industry |
|---|---|---|---|
| 1 Day | -2.26% | -0.25% | |
| 1 Week | -3.47% | -1.97% | |
| 1 Month | -15.87% | -5.24% | |
| 6 Months | -9.2% | 13.56% | |
| 1 Year | 21.23% | 45.64% |
Technical Trend
Pivot Levels
Moving Averages
| Period (Days) | SMA | Indication |
|---|---|---|
| 10 | 1283.34 | Bearish |
| 20 | 1349.56 | Bearish |
| 30 | 1392.09 | Bearish |
| 50 | 1438.29 | Bearish |
| 100 | 1431.83 | Bearish |
| 200 | 1275.24 | Bearish |
Shareholding Updates
Cash Flow
| Annual | FY 2024 | FY 2023 | FY 2022 | ||||
|---|---|---|---|---|---|---|---|
| Operating Activities | 2434.52 | 2386.75 | 5016.48 | ||||
| Investing Activities | -4255.95 | -3977.75 | -3211.56 | ||||
| Financing Activities | 800.42 | 1814.41 | -2969.27 | ||||
| Net Cash Flow | -1021.01 | 223.41 | -1164.35 |
All Figures in ₹ Cr., unless mentioned otherwise
Ratios
Income Statement
Balance Sheet
Peer Comparison
| Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
|---|---|---|---|---|---|
| Aurobindo Pharma | -2.26 | -3.47 | -15.87 | -9.2 | 21.23 |
| Alembic | -2.18 | -8.46 | -1.4 | -8.46 | -8.46 |
| Fortis Healthcare | 3.76 | 5.07 | 11.98 | 35.27 | 86.09 |
| Ajanta Pharmaceuticals | 0.02 | 4.02 | -5.81 | 11.37 | 44.69 |
| Advanced Enzyme Tech | -1.49 | -5.52 | -17.71 | -4.78 | 13.63 |
About Aurobindo Pharma
Aurobindo Pharma Share Price
Aurobindo Pharma Limited is an Indian pharmaceutical company. The main activity of the company is the production and distribution of active pharmaceutical ingredients, branded drugs, generic drugs and related services. Its product portfolio is divided into seven therapeutic/product areas which include CNS (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), SSP - Oral & Sterile, anti-infective, anti-diabetic and cephalosporins - orally. It develops various oncology and hormonal products. It develops topical and transdermal products for the therapeutic segment of dermatology. The company is also developing approximately three depot injections based on microsphere and nanosuspension technology platforms. The company distributes its products worldwide in about 150 countries. The company's subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited and others.
Aurobindo Pharma FAQs
How to Buy Aurobindo Pharma Share?
What's Aurobindo Pharma share price today?
What is the Market Cap of Aurobindo Pharma?
What is the PE and PB ratio of Aurobindo Pharma?
What is the 52 Week High and Low of Aurobindo Pharma Share?